Lanabecestat
id:
lanabecestat-275-15552785
title:
Lanabecestat
text:
Lanabecestat is an oral beta-secretase 1 cleaving enzyme (BACE) inhibitor. A BACE inhibitor in theory would prevent the buildup of beta-amyloid and may help slow or stop the progression of Alzheimer's disease. In September 2014, AstraZeneca and Eli Lilly and Company announced an agreement to co-develop lanabecestat. A pivotal Phase II/III clinical trial of lanabecestat started in late 2014 and is planned to recruit 2,200 patients and end in June 2019. In April 2016 the company announced it would
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Lanabecestat
date created:
date modified:
2024-03-28T03:01:02Z
main entity:
{"identifier":"Q19903502","url":"https://www.wikidata.org/entity/Q19903502"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/c/c7/Lanabecestat.svg","width":512,"height":296}
fields total:
13
integrity:
15